MedPlus Health Q3 net profit surges 26% on higher sales and new stores

Pharmacy retail chain MedPlus Health Services Ltd on Friday (January 30) reported a 26.2% year-on-year increase in net profit for the third quarter, with profit rising to ₹57.8 crore compared with ₹45.8 crore in the same period last year.

Revenue for the quarter grew 15.7% year-on-year to ₹1,806 crore from ₹1,561.4 crore. Sequentially, revenue grew 7.5% compared with Q2FY26, up ₹127 crore. The company’s private label business rose 2.6% over the same period last year.

Earnings before interest, tax, depreciation, and amortisation (EBITDA) increased 19.7% to ₹158.5 crore, up from ₹132.4 crore in Q3 of the previous year. The company’s EBITDA margin improved to 8.78% from 8.48% in the year-ago period.

Also Read: MedPlus Health Q2 net profit surges 43% YoY

Gross margin for the quarter stood at ₹472 crore, representing a 26.2% and an increase of 110 basis points YoY. MedPlus added 182 stores during the quarter, with 228 gross additions and 116 net additions beyond tier-I cities, taking the total store count to 5,112 as of December 31, 2025. Stores operational for over 12 months delivered 10.5% revenue growth over Q3FY25, with a store-level EBITDA margin of 12.4% and operating ROCE at 77.7%.

Pharmacy operating EBITDA for the quarter was ₹92.5 crore, reflecting a 5.2% operating margin, up 10 basis points sequentially. Company-level operating EBITDA stood at ₹96.8 crore. Operating cash flow reached ₹90.5 crore, covering 93.5% of operating EBITDA, while closing cash and bank balance was ₹608 crore.

Shares of MedPlus Health Services Ltd ended at ₹798., up by ₹25.70, or 3.33%, on the BSE today, January 30.

Also Read: MedPlus expects better same-store sales ahead, pushes harder on private labels